Online Inquiry

Orthogonal aaRS/tRNA Pair Identification

aaRS/tRNA pair identification centers on finding a decoder–synthetase combination that faithfully reads a reassigned codon (e.g., stop codon/quadruplet) and selectively charges the intended ncAA(Non-Canonical Amino Acids). Success depends on orthogonality, suppression efficiency, low background, and portability across host systems. The GCEngine platform provides an orthogonal aaRS/tRNA pair identification service that applies standardized reporters and controls to generate comparable metrics in E. coli, yeast, and mammalian cells.

About GCEngine

GCEngine is a genetic code expansion (GCE) platform built around orthogonal aaRS/tRNA engineering and codon reassignment. The GCEngine platform operates on the principle of codon reassignment in live or cell-free translation. A dedicated orthogonal aaRS/tRNA pair is engineered so that the aaRS activates the target non-canonical amino acid (ncAA) and charges its cognate tRNA; the tRNA anticodon (e.g., CUA) decodes a reassigned codon (e.g., UAG) at the ribosomal A-site, inserting the ncAA into the growing polypeptide.

Diagram of GCEngine platformFig.1 A schematicof ncAA incorporation by orthogonal aaRS/tRNA pairs. (Natter Perdiguero, A., et al., 2024)

About Orthogonal aaRS/tRNA Pair Identification

Pair identification integrates two converging tracks: a tRNA capable of decoding the target codon with minimal crosstalk, and a synthetase that charges the target ncAA with high selectivity. Engineering levers include anticodon choice (e.g., CUA), D/T/variable loop edits, acceptor-stem identity elements, active-site remodeling of the aaRS, and balancing expression to reduce release-factor competition and minimize codon-context dependence.

Our Services

A focused program couples tRNA selection with aaRS identification, using harmonized assays to quantify efficiency, background, and fidelity; campaigns are scoped to the codon strategy and host, enabling predictable decisions without rebuilding the assay backbone.

tRNA Selection defines codon strategy and host, surveys orthogonal scaffolds (Pyl-type, engineered Tyr-type, archaeal variants), and—where justified—introduces focused or semi-random diversity across anticodon and loop/identity elements. Host-optimized expression cassettes are built; ncAA-dependent positive/negative selection and reporter readouts quantify suppression while context and expression balance are tuned to suppress background.

aaRS Identification matches a synthetase to the selected decoder and ncAA panel, profiling candidate scaffolds under survival selections and reporter assays with counter-selection against canonical mischarging. Active-site and distal residues may be diversified to expand sensitivity or substrate scope; orthogonality is verified via omission/swap controls, and promoter/copy-number parameters are adjusted to stabilize performance in the chosen host.

Contact Us

Take the next step in unlocking your orthogonal aaRS/tRNA pairing capabilities. Let us help you design, identify, and validate the perfect decoding pair for your ncAA project. Contact us today to get started with a customized plan, timelines, and a clear path to successful implementation across all host systems.

Reference

  1. Natter Perdiguero, A., & Deliz Liang, A. (2024). Practical Approaches to Genetic Code Expansion with Aminoacyl-tRNA Synthetase/tRNA Pairs. Chimia, 78(1-2), 22–31.
Rare Skin Diseases

A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.

Contact Us